Summary (tl;dr)

Actress Chrissy Metz, known for her role in "This Is Us," is trending after recently revealing she is using GLP-1 medication for weight management, citing personal health reasons, family history of obesity, and perimenopause as factors in her decision. She has partnered with the telehealth company Ro and reports positive results, including significant weight loss and improved mobility for her current Broadway role.

Essential Background

Chrissy Metz has long been a public figure whose weight and health journey have been a topic of discussion. Prior to her recent announcement, she had openly shared her experiences with weight loss, including a reported 100-pound loss by April 2025 through strength training and diet, at which time she stated she was not using weight loss drugs. Her candidness about body image and health has resonated with many, setting a precedent for public interest in her personal choices.

The Full Story

Chrissy Metz is currently trending due to her recent public disclosure that she is utilizing GLP-1 (Glucagon-like peptide-1) medication to manage her weight. In interviews published on August 10th and 11th, 2026, Metz explained that while she was initially skeptical about GLP-1s, she decided to pursue this treatment after years of trying various diets and therapies without lasting success and observing family members, including her father, struggle with obesity-related health issues. Now 45 and in perimenopause, she emphasized her decision to prioritize her health and well-being. Metz has partnered with Ro, a digital health company that provides access to GLP-1 treatments and clinical care. She reports a positive experience, noting a loss of over 60 pounds and benefits such as increased mobility, reduced joint pain, and a quieter "food noise" that previously consumed her thoughts. These improvements have notably aided her performance in the Broadway musical "& Juliet."

Why It Matters

Chrissy Metz's revelation is significant as it adds a prominent voice to the ongoing public conversation surrounding GLP-1 medications for weight loss. Her openness helps destigmatize the use of such medications, framing it as a personal health choice rather than a "shortcut." Given her established platform and prior public journey with weight, her experience resonates with many individuals facing similar health challenges and seeking effective solutions. The trend also highlights the growing adoption of GLP-1 drugs, moving the discussion from purely medical circles into mainstream celebrity and health news, influencing public perception and interest in these treatments.

Geographic Location

• New York City, New York, United States (location of TODAY show interview and Broadway performance in "& Juliet")